Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

November 30, 2006

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

hypertonic saline

inhaled hypertonic saline (at a dose of 5 ml of a 3% solution) three times a week, combined with a program of physical exercises.

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00639236 - Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter